Cash Flow from Operating Activities: A company's cash flows from operations.
Tyra Biosciences, Inc. (TYRA) had Cash Flow from Operating Activities of $-95.14M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-33.83M |
|
-- |
|
-- |
|
$36.52M |
|
$-36.52M |
|
$2.68M |
|
$-33.83M |
|
$-33.83M |
|
$-33.83M |
|
$-33.83M |
|
$-33.83M |
|
$-33.83M |
|
$-36.52M |
|
$-36.38M |
|
59.60M |
|
59.60M |
|
$-0.57 |
|
$-0.57 |
|
| Balance Sheet Financials | |
$265.45M |
|
$1.31M |
|
$17.16M |
|
$282.61M |
|
$18.09M |
|
-- |
|
$5.34M |
|
$23.43M |
|
$259.18M |
|
$259.18M |
|
$259.18M |
|
53.71M |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$-95.14M |
$72.46M |
|
$8.10M |
|
$92.97M |
|
$78.39M |
|
$-14.58M |
|
$28.01M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-95.28M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-13.05% |
|
-13.05% |
|
-11.97% |
|
-13.05% |
|
$4.83 |
|
$-1.60 |
|
$-1.60 |
|